Business Courses

Circulating Tumor Cells (CTCs): Technology Analysis, Market Analysis, and Clinical Utility

This Business Course is being held in San Diego, CA, USA on the 22 January 2013 at 18:00-20:00

Price:

Enal Razvi Managing Director, Select Biosciences Inc

Scope of this Tutorial

This course explores the emerging field of CTCs from both a technology as well as market/business perspective.  The data and analysis presented in this course is based upon Select Biosciences tracking of this emerging field and Select Biosciences best-selling market & technology analysis reports on this topic.

The value of this course will be to researchers from academic institutions, commercial entities such as biotechnology and pharmaceutical companies seeking a thorough understanding of the scientific and business factors in this space, as well as industry participants such as venture capitalists, investors, and patent attorneys.

All attendees to this training course receive the electronic files of the presentation material on disk with full rights to use them in their internal R&D as well as business planning activities.

Specific Presentation Topics

• History and biological definition of CTCs
• Biological role of CTCs in cancer progression and metastasis
• CTC isolation and purification technologies:
• Comparison of platforms
• Companies in the Space
• Survey of scientific research: Utility of CTCs in Cancer Diagnostics and Prognostics
• Market penetrance of different markers for characterizing CTCs
• Primary Market Research Data are Presented
• Market penetrance of methodologies utilized for studying CTCs currently
• Based on Primary Market Surveys of Researchers Worldwide
• Market Segmentation, Market Sizing, and Growth Rates of the Individual Market Segments
• Industry SWOT Analysis
• Market Opportunities in Various Application Areas of the CTCs Space
• Qualitative Trends
• Quantitative Analysis
• Clinical Trials in the CTCs Field

For more information, please e-mail Kathy Gray at k.gray@selectbio.com